Reazent

Reazent is a Canadian company that has developed a patented technology to organically replace agrochemicals. The company focuses on loading plant growth-promoting rhizobacteria (PGPRs) to treat the soil and the plant. The company states that its technology can be applied across a wide range of crops such as soybean, peanuts, wheat, kale, and lettuce.

Studies show that only 0.1% PGPR strains have been commercialized to date. Reazent claims that its competitive advantage is that it can work with up to 116 PGPR strains and has identified that soil bacteria have a second metabolite that can be used to up-regulate plant defense and root growth genes in plants. The company further claims that its technology helps in achieving an improvement of 5x in the plant’s immune system, thereby providing protection against pesticides as well.

As of June 2022, the company has not commercialized and is actively working on obtaining regulatory approval for the sale of its products in Canada and the US. Based on trials conducted in 2020 across different growing conditions, its product has demonstrated a 400% increase in soybean root nodules, a 30% increase in peanuts above-ground biomass, and up to a 35% increase in peanuts pod dry weight when compared with synthetic and other organic products. In October 2020, the company reported that it had many trials underway, including for tomato, and was expecting results by December 2021. The company noted in November 2021 that it would be extensively trialing its fertilizer product for soybeans in North America, Brazil, and India during the following growing season.

Funding and financials

In May 2020, the company received CAD 350,000 (USD 250,000) in seed funding as part of joining IndieBio’s accelerator program. The funds were to be used to conduct trials for its prototype fertilizer product at the Verschuren Center for Sustainability in Energy and the Environment at Cape Breton University ass well as to develop its product for large-scale trials. In February 2023, the company raised USD 15,600 from Natural Products Canada, a non-profit organization that supports Canadian bio-based innovation and commercialization to fast-track the development of a regulatory plan.